Testing effectiveness (Phase 2)Study completedNCT03166215
What this trial is testing
Study of TAK-935 as an Adjunctive Therapy in Participants With Developmental and/or Epileptic Encephalopathies
Who this might be right for
Developmental and/or Epileptic Encephalopathies
Takeda 18